We are live on ! Find out more

GNMK

GenMark Diagnostics, Inc

GNMK

Delisted

GNMK was delisted on the 21st of April, 2021.

106 hedge funds and large institutions have $400M invested in GenMark Diagnostics, Inc in 2018 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 34 increasing their positions, 34 reducing their positions, and 10 closing their positions.

New

Increased

Maintained

Reduced

Closed

13% more capital invested

Capital invested by funds: $355M → $400M (+$45.8M)

10% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 10

1% more funds holding

Funds holding: 105 → 106 (+1)

0% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 34

Holders

106

Holders Change

Holders Change %

+0.95%

% of All Funds

2.42%

Holding in Top 10

–

Holding in Top 10 Change

–

Holding in Top 10 Change %

–

% of All Funds

–

New

Increased

Reduced

Closed

Calls

–

Puts

–

Net Calls

–

Net Calls Change

–

Top Buyers

Rank	Fund	Capital Flow
1	Deutsche Bank Frankfurt Am Main Ge, Germany	+$1.93M
2	BlackRock New York	+$1.84M
3	State Street Boston, Massachusetts	+$1.4M
4	BG Bellevue Group Kuesnacht, Switzerland	+$1.12M
5	D.E. Shaw & Co New York	+$842K

Top Sellers

Rank	Fund	Capital Flow
1	Alyeska Investment Group Chicago, Illinois	-$7.28M
2	CCM Cadian Capital Management New York	-$4.76M
3	PI Putnam Investments Boston, Massachusetts	-$1.52M
4	T. Rowe Price Associates Baltimore, Maryland	-$1.47M
5	Morgan Stanley New York	-$1.2M

#	Name	Holding	Trade Value	Shares Change	Change in Stake
26	26 Bank of New York Mellon New York	$1.59M	-$9.12K	-1,243	-0.6%
27	27 Federated Hermes Pittsburgh, Pennsylvania	$1.47M	–	–	–
28	KCM 28 Kennedy Capital Management St Louis, Missouri	$1.42M	-$15.3K	-2,092	-1%
29	29 Jacobs Levy Equity Management Florham Park, New Jersey	$1.4M	+$125K	+17,023	+10%
30	30 TD Asset Management Toronto, Ontario, Canada	$1.39M	+$63.1K	+8,600	+5%
31	BCM 31 Bridgeway Capital Management Houston, Texas	$1.32M	–	–	–
32	32 Two Sigma Investments New York	$1.29M	-$73.4K	-10,008	-5%
33	33 Russell Investments Group London, United Kingdom	$1.18M	-$90.6K	-12,344	-7%
34	TCIM 34 TIAA CREF Investment Management New York	$1.15M	-$44.8K	-6,108	-4%
35	35 Two Sigma Advisers New York	$1.11M	+$39.6K	+5,400	+4%
36	WMSA 36 Weiss Multi-Strategy Advisers New York	$959K	-$290K	-39,474	-23%
37	TA 37 Teachers Advisors New York	$950K	+$7.5K	+1,022	+0.8%
38	GIP 38 Granite Investment Partners El Segundo, California	$823K	+$82.8K	+11,280	+11%
39	LSC 39 Lyon Street Capital Sausalito, California	$807K	+$806K	+109,850	New
40	BFS 40 Bradley Foster & Sargent Hartford, Connecticut	$750K	–	–	–
41	41 William Blair & Company Chicago, Illinois	$686K	-$22K	-3,000	-3%
42	42 Swiss National Bank Zurich, Switzerland	$654K	–	–	–
43	RA 43 Royce & Associates New York	$652K	–	–	–
44	DCM 44 Donaldson Capital Management Evansville, Indiana	$610K	–	–	–
45	45 California State Teachers Retirement System (CalSTRS) West Sacramento, California	$583K	+$3.85K	+524	+0.7%
46	46 Goldman Sachs New York	$573K	-$17.9K	-2,438	-3%
47	47 UBS AM Chicago, Illinois	$459K	-$42.6K	-5,807	-9%
48	48 AllianceBernstein Nashville, Tennessee	$410K	–	–	–
49	FC 49 Fairpointe Capital Chicago, Illinois	$387K	–	–	–
50	ARTA 50 A.R.T. Advisors New York	$375K	-$112K	-15,200	-23%

GNMK Hedge Fund Activity: Q3 2018 in Review

106 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in GenMark Diagnostics, Inc (GNMK) for Q3 2018, worth a combined $400M — up 13% from $355M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new GNMK positions and 10 closed out — a net gain of 1 holder — while 34 added to existing stakes and 34 trimmed.

The largest buyer was Deutsche Bank, adding an estimated $1.93M. The largest seller was Alyeska Investment Group, cutting an estimated $7.28M.

106 institutional investors held GenMark Diagnostics, Inc (GNMK) as of Q3 2018, up from 105 in Q2 2018.
Funds reported $400M of GenMark Diagnostics, Inc stock for Q3 2018, up 13% quarter-over-quarter.
11 funds opened new GenMark Diagnostics, Inc positions in Q3 2018 and 10 closed out, a net change of +1 holder.
The largest GenMark Diagnostics, Inc buyer in Q3 2018 was Deutsche Bank, an estimated $1.93M added.
The largest GenMark Diagnostics, Inc seller in Q3 2018 was Alyeska Investment Group, an estimated $7.28M sold.

Based on aggregated 13F filings for Q3 2018.

GenMark Diagnostics, Inc GNMK